{"id":1019990,"date":"2026-11-11T10:38:33","date_gmt":"2026-11-11T15:38:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/"},"modified":"2026-11-11T10:38:33","modified_gmt":"2026-11-11T15:38:33","slug":"lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/","title":{"rendered":"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London"},"content":{"rendered":"<div class=\"mw_release\">\n<p>THE WOODLANDS, Texas, Nov.  11, 2026  (GLOBE NEWSWIRE) &#8212; Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London.<\/p>\n<p>The live event and a replay of the presentation can be accessed via the Events page of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dbG0O86fwzee_wpBnRR425XPdmIe76MbOwXm9IQkWapl4fUgj2X3UD9R8UK6w_fsu5mC7ZNjKDlszXwySgYcnVgYrsn-h6Bw7G7b68YJT3xXd2olvxOu7cB4O1jzhyTS\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.lexpharma.com\/<\/a>.<\/p>\n<p>\n        <strong>About Lexicon Pharmaceuticals<\/strong>\u00a0<\/p>\n<p align=\"justify\">Lexicon Pharmaceuticals is a biopharmaceutical company pursuing novel medicines for patients with serious cardiometabolic diseases. Building on a proven legacy in genetic target discovery, Lexicon is advancing a clinical pipeline in areas of significant and often underserved need, with programs in hypertrophic cardiomyopathy (HCM), type 1 diabetes (T1D), obesity and other related metabolic conditions. Lexicon is committed to developing differentiated therapies that can be integrated broadly into clinical practice, with the goal of expanding treatment options for patients. Its capabilities extend from early-stage target discovery through clinical development and commercialization, strategically paired with high-impact collaborations to maximize the global reach of its medicines.<\/p>\n<p align=\"justify\">For\u00a0additional\u00a0information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w-nXIGVjGtXeeA88Hw0yAByAwaG2nvVHgZckP3QidMj8IehnwSw67kpXer18RgiFxeBN7V0_YhfwvfXee50C3eFkrV8mJO7V9R1knRLi1eQsyDV8gq5OXuYVbLcfSG4MIHSEmMqp8NXUA26gvInk_psXAmWQw8QEtuQEmrSSLWgGdLM0asG6Vdi7hpoCC9BdwcwhlFw1Z9lxBp6alXD_1G9UXIV_VpGKQCXcKaGkegslZVMvcU8_YWvDOS0BAaygRMnSmhdziR-1G0lRO3KZSNNwdtZV8wieQ87dT2Cm7w4GBRjsckIHoT__JxhdCBiwO16jrlGu4ICV54kHtsOJolTAYwBMh2nWNYZRdoGOU_DW3wTV_rUG-bPbN0U0i5TdkFU7QVJzcN_Hix5t8vbuL5wjM9oN8GzRv6wub47iHescMf5lA8ib2qt0QrqGp7mnbmPs2T_NE4bcHNEfUwIiy2cF3xDQMGF_l9wVKeiAQGyCF548m4FMT-arOmHByIJGRuWwKiFDp5yNShYs2xRImX-NFe71v2SO9_OfCBIacMhQLilxOegH9-hGYtkNAO6iHmF1KSUbQFLq1lnOd8oMCG15s1_AbdunO0XmaK3pwir_4PSizISFtBqA4y9UEVcCQdWrnOWccwXCK0kth5KOavFJO-csw1P-LFJHmsdHg9lPIUcRF69ptEsZf3X9Y6YAVId1yMtal5oljPWmfUeflBR8-xgNdkfmr8nhvpS3M3fnzvQj6DHhtgRWp7Mq8HLNSp6_gnT3jqJ5snAozf3prQ==\" rel=\"nofollow\" target=\"_blank\">www.lexpharma.com<\/a>.<strong>\u00a0\u00a0\u00a0<\/strong><\/p>\n<p>\n        <strong>For Media Inquiries:<\/strong><br \/>\n        <br \/>Dave Belian<br \/>Lexicon Pharmaceuticals, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LcdZAAdu705utA-HV431P4dHzCMw9q6qeNnC2O5OFrtBMO3eQyzhhd7IikJa8crkI3Mah25VUWmWcwaP3sdDya-NzlQSTzY9bzcO_REkHSI=\" rel=\"nofollow\" target=\"_blank\">lexinvest@lexpharma.com<\/a><\/p>\n<p>\n        <strong>For Investor Inquiries:<\/strong><br \/>\n        <br \/>Lisa DeFrancesco<br \/>Lexicon Pharmaceuticals, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LcdZAAdu705utA-HV431P4dHzCMw9q6qeNnC2O5OFrs2V2jjnaboRknkrOZGYzgTCLRjkv1K7GK8_5VDydcTCqA8RH0PzbJfd0vKaXh9j8w=\" rel=\"nofollow\" target=\"_blank\">lexinvest@lexpharma.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjdhYjFiYTAtNmZkZi00YzAxLWI1OTgtMzM4ZjU4N2NkNjE2LTEwMTU1NDAtMjAyNi0xMS0xMS1lbg==\/tiny\/Lexicon-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>THE WOODLANDS, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) &#8212; Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London. The live event and a replay of the presentation can be accessed via the Events page of the Company\u2019s website at https:\/\/investors.lexpharma.com\/. About Lexicon Pharmaceuticals\u00a0 Lexicon Pharmaceuticals is a biopharmaceutical company pursuing novel medicines for patients with serious cardiometabolic diseases. Building on a proven legacy in genetic target discovery, Lexicon is advancing a clinical pipeline in areas of significant and often underserved need, with programs in hypertrophic cardiomyopathy (HCM), type 1 diabetes &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1019990","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"THE WOODLANDS, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) &#8212; Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London. The live event and a replay of the presentation can be accessed via the Events page of the Company\u2019s website at https:\/\/investors.lexpharma.com\/. About Lexicon Pharmaceuticals\u00a0 Lexicon Pharmaceuticals is a biopharmaceutical company pursuing novel medicines for patients with serious cardiometabolic diseases. Building on a proven legacy in genetic target discovery, Lexicon is advancing a clinical pipeline in areas of significant and often underserved need, with programs in hypertrophic cardiomyopathy (HCM), type 1 diabetes &hellip; Continue reading &quot;Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-11T15:38:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London\",\"datePublished\":\"2026-11-11T15:38:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/\"},\"wordCount\":215,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/\",\"name\":\"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=\",\"datePublished\":\"2026-11-11T15:38:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/","og_locale":"en_US","og_type":"article","og_title":"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London - Market Newsdesk","og_description":"THE WOODLANDS, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) &#8212; Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London. The live event and a replay of the presentation can be accessed via the Events page of the Company\u2019s website at https:\/\/investors.lexpharma.com\/. About Lexicon Pharmaceuticals\u00a0 Lexicon Pharmaceuticals is a biopharmaceutical company pursuing novel medicines for patients with serious cardiometabolic diseases. Building on a proven legacy in genetic target discovery, Lexicon is advancing a clinical pipeline in areas of significant and often underserved need, with programs in hypertrophic cardiomyopathy (HCM), type 1 diabetes &hellip; Continue reading \"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-11T15:38:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London","datePublished":"2026-11-11T15:38:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/"},"wordCount":215,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/","name":"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=","datePublished":"2026-11-11T15:38:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3NDkxNiM3OTU4NTM1IzIwMDM5Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference-in-london\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1019990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1019990"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1019990\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1019990"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1019990"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1019990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}